Latest Breaking News On - Matthew chandler rob patrick - Page 6 : comparemela.com

Investegate |Midatech Pharma PLC Announcements | Midatech Pharma PLC: R&D Programme Focused on Leptomeningeal Disease

Investegate announcements from Midatech Pharma PLC, R&D Programme Focused on Leptomeningeal Disease

United kingdomUnited statesCity ofDmitry zamoryakhinMatthew chandler rob patrickTim metcalfe grahamEdison group us investor relationsAdvisory limited financialMidatech pharmaStrand hanson limited nominated adviserExchange commissionLondon stock exchangePreclinical rd programme focusedChemoresistant ovarianIntj molHanson limited

Midatech Pharma PLC Announces R&D Programme Focused on Leptomeningeal Disease

ABINGDON, OXFORDSHIRE / ACCESSWIRE / March 27, 2023 / Midatech Pharma PLC (AIM:MTPH.L)(Nasdaq:MTP), a drug delivery technology company focused on improving the bio-delivery and bio-distribution of medicines

United kingdomUnited statesCity ofMatthew chandler rob patrickMidatech pharma plcviewDmitry zamoryakhinTim metcalfe grahamEdison group us investor relationsStrand hanson limited nominated adviserLondon stock exchangeMidatech pharmaAdvisory limited financialExchange commissionChemoresistant ovarianIntj molHanson limited

Midatech Pharma (MTP) Announces R&D Programme Focused on Leptomeningeal Disease

Midatech Pharma (MTP) Announces R&D Programme Focused on Leptomeningeal Disease
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomCity ofUnited statesTim metcalfe grahamMatthew chandler rob patrickDmitry zamoryakhinExchange commissionStrand hanson limited nominated adviserLondon stock exchangeAdvisory limited financialEdison group us investor relationsMidatech pharmaWall streetChemoresistant ovarianIntj molHanson limited

Investegate |Midatech Pharma PLC Announcements | Midatech Pharma PLC: Results of General Meeting

Investegate announcements from Midatech Pharma PLC, Results of General Meeting

United statesUnited kingdomCity ofMatthew chandler rob patrickTim metcalfe grahamEuropean union withdrawalMidatech pharmaBiodexa pharmaceuticalsCompany american depositary shares adssEdison group us investor relationsCompany shareholderStrand hanson limited nominated adviserAdvisory limited financialCompany the ordinaryLondon stock exchangeExchange commission

Midatech Pharma PLC Announces Results of General Meeting

Share Consolidation, Change of Name, Adoption of New Articles and Cancellation of Admission to Trading on AIMABINGDON, OXFORDSHIRE / ACCESSWIRE / March 24, 2023 / Midatech Pharma PLC (AIM:MTPH)(Nasdaq:MTP)

City ofUnited kingdomUnited statesMatthew chandler rob patrickMidatech pharma plcviewTim metcalfe grahamCompany the ordinaryMidatech pharmaLondon stock exchangeCompany american depositary shares adssCompany shareholderFinancial conduct authorityEuropean union withdrawalStrand hanson limited nominated adviserAdvisory limited financialEdison group us investor relations